Since 1974, MIT has been a National Cancer Institute-designated basic cancer center, first as the MIT Center for Cancer Research and now as the Koch Institute. The NCI designation brings a major source of federal funding through the Cancer Center Support Grant (CCSG). Notable benefits include support for core research facilities and selected staff members, training and development programs for our community, and additional funding opportunities for our investigators. The CCSG helps the Koch Institute apply our great strengths in biology and engineering, and working closely with our clinical collaborators, we are deeply committed to creating knowledge, tools, and treatments to fight cancer.
